September 2019

By Kip Meadows, Founder and CEO of Nottingham. The launch of four new cannabis ETFs in 2019, paired with the recent filing for yet another one, has many investors wondering how to navigate amongst the options as they seek exposure to the growing cannabis industry. There are significant differences among the current options, or at […]

by

New cannabis-focused real estate company, NewLake Capital Partners announced Friday it has completed a private placement of $85.5 million in preferred stock, having its first draw of capital on Aug. 28. New Lake is a Maryland corporation that works on obtaining industrial and retail properties to be leased to licensed cannabis companies. It said it […]

by

Havas ECS, the endocannabinoid consultancy firm that’s a subsidiary of international advertising and public relations company Havas Group (owned by Vivendi SA (OTC: VIVEF)), last week announced the launch of a full spectrum education program for the medical and legal communities, aimed at filling the gap of misinformation that exists between cannabis science, legislation, and the […]

by

Havas ECS, the endocannabinoid consultancy firm that’s a subsidiary of international advertising and public relations company Havas Group (owned by Vivendi SA (OTC: VIVEF)), last week announced the launch of a full spectrum education program for the medical and legal communities, aimed at filling the gap of misinformation that exists between cannabis science, legislation, and the […]

by

Cannabis has been extending its reach through legalization over the past several years. Starting with early adopter Colorado, 37 states have passed legislation allowing adult consumption for medical and, in some cases, recreational purposes. So how high can revenues go for this budding industry? For 2018, revenue from both legal recreational and medical cannabis in […]

by

Cannabis has been extending its reach through legalization over the past several years. Starting with early adopter Colorado, 37 states have passed legislation allowing adult consumption for medical and, in some cases, recreational purposes. So how high can revenues go for this budding industry? For 2018, revenue from both legal recreational and medical cannabis in […]

by